Draft genome sequence of <i>Bordetella pertussis</i> PS21, a circulating clinical isolate from India. [PDF]
Irulappan M +7 more
europepmc +1 more source
Limited response of primary nasal epithelial cells to <i>Bordetella pertussis</i> infection. [PDF]
Zmuda M +5 more
europepmc +1 more source
Seroprevalence of <i>Bordetella pertussis</i> in patients with COPD in a UK cohort. [PDF]
Richardson H +5 more
europepmc +1 more source
Author Correction: Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice. [PDF]
Jazayeri SD +3 more
europepmc +1 more source
An endogenous human peptide derived from α<sub>1</sub>-antitrypsin as a novel pharmacological inhibitor of Bordetella pertussis toxin. [PDF]
Lietz S +14 more
europepmc +1 more source
No innocent bystanders: pertussis vaccination and evolutionary parallelisms between <i>Bordetella parapertussis</i> and <i>Bordetella pertussis</i>. [PDF]
Bouchez V +12 more
europepmc +1 more source
Comparing Respiratory Illness Surveillance Case Definitions to Detect Bordetella pertussis in Children Aged <5 Years With Respiratory Illness in South Africa, 2017-2023. [PDF]
Bishop K +15 more
europepmc +1 more source
The 2024 resurgence of <i>Bordetella pertussis</i> in Brazil and a decade-long epidemiological overview. [PDF]
Sansone NMS, Boschiero MN, Marson FAL.
europepmc +1 more source
<i>Bordetella pertussis</i> exhibits genomic diversity within patients and laboratory culture. [PDF]
Bouda E +21 more
europepmc +1 more source
Interferon lambda signaling in neutrophils enhances the pathogenesis of Bordetella pertussis infection. [PDF]
Kumar A +4 more
europepmc +1 more source

